The use of methylphenidate among students: the future of enhancement?
- 25 March 2010
- journal article
- research article
- Published by BMJ in Journal of Medical Ethics
- Vol. 36 (4), 198-202
- https://doi.org/10.1136/jme.2009.034421
Abstract
During the past few years considerable debate has arisen within academic journals with respect to the use of smart drugs or cognitive enhancement pharmaceuticals. The following paper seeks to examine the foundations of this cognitive enhancement debate using the example of methylphenidate use among college students. The argument taken is that much of the enhancement debate rests upon inflated assumptions about the ability of such drugs to enhance and over-estimations of either the size of the current market for such drugs or the rise in popularity as drugs for enhancing cognitive abilities. This article provides an overview of the empirical evidence that methylphenidate has the ability to significantly improve cognitive abilities in healthy individuals, and examines whether the presumed uptake of the drug is either as socially significant as implied or growing to the extent that it requires urgent regulatory attention. In addition, it reviews the evidence of side-effects for the use of methylphenidate which may be an influential factor in whether an individual decides to use such drugs. The primary conclusions are that neither drug efficacy, nor the benefit-to-risk balance, nor indicators of current or growing demand provide sufficient evidence that methylphenidate is a suitable example of a cognitive enhancer with mass appeal. In light of these empirically based conclusions, the article discusses why methylphenidate might have become seen as a smart drug or cognitive enhancer.Keywords
This publication has 37 references indexed in Scilit:
- Responding to requests from adult patients for neuroenhancementsNeurology, 2009
- Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurologyJournal of Medical Ethics, 2009
- Risks and benefits may turn out to be finely balancedNature, 2009
- Towards responsible use of cognitive-enhancing drugs by the healthyNature, 2008
- Safety of therapeutic methylphenidate in adults: a systematic review of the evidenceJournal of Psychopharmacology, 2008
- Professor's little helperNature, 2007
- ‘I Bambini e le Droghe’: The Right to Ritalin vs the Right to Childhood in ItalyBioSocieties, 2007
- The promise and predicament of cosmetic neurologyJournal of Medical Ethics, 2006
- Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effectsHuman Psychopharmacology: Clinical and Experimental, 2004
- 'Smart Drugs': do they work? Are they ethical? Will they be legal?Nature Reviews Neuroscience, 2002